Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5537079 | Vaccine | 2017 | 10 Pages |
Abstract
Invasive pneumococcal diseases and pneumonia rates among the adult population decreased in most countries following PCV introduction into the NIP. This indirect effect on older population seems to be dependent on PCV coverage rates and time from PCV nationwide implementation. Adults >65Â years old seem to benefit the most from PCV introduction.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Gal Tsaban, Shalom Ben-Shimol,